CLINICAL_TRIALS
trial_result
· 2015-01-30
Clinical Trial Update: A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED) [Phase 3]
Summary
A Phase 3 trial evaluating an investigational drug for obesity has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 3 | Status: COMPLETED